SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: Cymeed who wrote (549)12/18/1997 6:36:00 PM
From: seminole  Read Replies (1) | Respond to of 887
 
Here is a little more information.

moneynet.com

Eight of 31 depocyte patients and 6 of 30 methotrexate patients had no worsening of disease, the reviewer said.

"Depocyte has activity that is not statistically different from methotraxate in patients with solid tumors," said FDA reviewer
Steve Hirschfeld.

richard



To: Cymeed who wrote (549)12/18/1997 6:40:00 PM
From: scott harrison  Read Replies (2) | Respond to of 887
 
To all: I think we'll open at 4 or 5. We'll probably settle higher. (6 or 7?) scott


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News